1082989-83-0

Basic information

• Product Name: (5-fluoro-2,4-dinitro-phenyl)-acetic acid
• Synonyms: (5-fluoro-2,4-dinitro-phenyl)-acetic acid
• CAS NO: 1082989-83-0
• Molecular Weight: 244.136
• Mol File: 1082989-83-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (5-fluoro-2,4-dinitro-phenyl)-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (5-fluoro-2,4-dinitro-phenyl)-acetic acid(1082989-83-0)
• EPA Substance Registry System: (5-fluoro-2,4-dinitro-phenyl)-acetic acid(1082989-83-0)

Safety Data

• Hazardous Substances Data: 1082989-83-0(Hazardous Substances Data)

Upstream product

• 331-25-9 (3-fluorophenyl)acetic acid 

Downstream Products

• 1082989-85-2 (2,4-diamino-5-fluoro-phenyl)-acetic acid 
• 150544-00-6 methyl (5-fluoro-2,4-dinitrophenyl)acetate 

Relevant articles and documents

PYRROLO-NITROGENOUS HETEROCYCLIC DERIVATIES,THE PREPARATION AND THE PHARMCETICAL USE THEEOF

The invention provides new pyrrolo-nitrogenous heterocyclic derivatives represented by formula (I) or their salts, the preparation thereof, pharmaceutical compositions containing such derivatives and the use of such derivatives as therapeutic agents, especially as protein kinase inhibitors, wherein each substituent in formula (I) is same as defined in the description.

2-(2-OXOINDOLINE-3-YLIDENE)METHYL-5-(2-HYDROXY-3-MORPHOLIN-4-YL -PROPYL)-6,7-DIHYDRO -1H- PYRROL[3,2-C]PYRIDINE-4(5H)-ONE COMPOUNDS AND USE AS PROTEIN KINASE INHIBITORS

Pyrrolo[3,2-c]pyridine-4-one-2-indolinone compounds, especially 2-(2-oxoindoline-3-ylidene)methyl-5-(2-hydroxy-3-morpholin-4-yl-propyl)-6,7-dihyd ro-1H-pyrrol[3,2-c]pyridine-4(5H)-one compounds. Their preparation and pharmaceutical composition, and pharma

IMIDAZOLE DERIVATIVES AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS

In its many embodiments, the present invention provides imidazole derivatives which are inhibitors of alPha2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition or amelioration of one or more conditions associated with the alpha2C adrenergic receptors using such compounds or pharmaceutical compositions. Formula (I).